Goldamycin

Goldamycin is an oral, prescription‑only medication that contains the macrolide antibiotic azithromycin as its active ingredient; the specific strength and dosage form are not disclosed in the available product information. It is marketed in the European Union and belongs to the antibacterial therapeutic class. Goldamycin works by inhibiting bacterial protein synthesis, making it useful for treating a range of bacterial infections in everyday clinical practice worldwide.

Goldamycin (azithromycin) is prescribed for several bacterial infections that are commonly encountered in outpatient settings.

- Community‑acquired pneumonia - Acute bacterial sinusitis - Acute otitis media - Pharyngitis or tonsillitis - Skin and soft‑tissue infections - Chlamydia trachomatis infection

Side effects of Goldamycin vary in frequency and severity.

Common: - Nausea or upset stomach - Diarrhea or loose stools - Abdominal pain or cramping - Headache - Altered taste sensation - Vomiting

Serious: - Severe allergic reactions (e.g., rash, swelling, anaphylaxis) - QT‑interval prolongation leading to cardiac arrhythmias - Elevated liver enzymes indicating hepatic stress - Clostridioides difficile‑associated colitis - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When prescribing Goldamycin, clinicians should consider several precautionary factors.

- Assess liver and kidney function before initiating therapy - Use cautiously in patients with known prolonged QT interval or cardiac disease - Pregnancy and breastfeeding safety have not been established; evaluate risk‑benefit - Avoid in individuals with a documented macrolide allergy - Monitor for signs of antibiotic resistance during prolonged courses - Adjust dosing in pediatric patients according to weight and age guidelines

Goldamycin can interact with other medicines, affecting safety or effectiveness.

Avoid: - Concurrent use with other QT‑prolonging agents (e.g., certain antiarrhythmics, fluoroquinolones) - Ergot alkaloids, which may cause severe vasospasm - Strong CYP3A4 inducers that reduce azithromycin levels

Use with caution: - Warfarin, as azithromycin may increase anticoagulant effect - Oral contraceptives, which may have reduced efficacy - Antacids containing aluminum or magnesium, which can impair absorption - Digoxin, due to potential increased serum concentrations - Colchicine, especially in patients with renal impairment